Latest News

  • KALBE Provides COVID-19 Examination Services Using Reverse Transcription Polymerase Chain Reaction (RT-PCR) to Support the Government

    Thursday, April 16, 2020
    KALBE Provides COVID-19 Examination Services Using Reverse Transcription Polymerase Chain Reaction (RT-PCR) to Support the Government

    Jakarta, April 16, 2020, PT Kalbe Farma Tbk (Kalbe) through its subsidiary, KalGen-Innolab Clinical Laboratory, is ready to provide COVID-19 examination services using the Reverse Transcription Polymerase Chain Reaction (RT-PCR), the gold standard for COVID-19 examinations by detection of SARS-COV2 viral RNA that is acclaimed by Indonesian and international governments. KalGen Innolab is equipped with facilities of Biosafety Level 2+ (BSL2+) category, cutting-edge equipment, and trained human resources adhering to the requirements set by the Ministry of Health of the Republic of Indonesia through an official circular letter from the Minister of Health No.HK.02.01/Menkes/234/2020 regarding Guidelines for Laboratories conducting COVID-19 examination with RT-PCR. 

  • Enseval in Cooperation with the Indonesian Pharmacists Association Help Overcome COVID-19 Pandemic

    Tuesday, April 7, 2020
    Enseval in Cooperation with the Indonesian Pharmacists Association Help Overcome COVID-19 Pandemic

    Jakarta, April 7, 2020 - PT Kalbe Farma Tbk (Kalbe) through one of its subsidiary entities , PT Enseval Putera Megatrading Tbk (Enseval)  is assisting in the distribution of logistical aid from the Central Management Board of the Indonesian Pharmacist Association (PP IAI) to 34 Regional IAI Administrations throughout Indonesia. The logistical assistance from PP IAI takes the form of products and medical devices consisting of masks, hand-cleansers, plastic gloves, vitamins, and tea bags will be distributed to pharmacists on duty in pharmaceutical services who continue to perform services during the COVID-19 pandemic. The aid package was handed over by Drs (Apt) Nurul Falah Eddy Pariang, Chairperson of PP IAI; to Berty Argiyantari, Deputy Director of Logistics at PT Enseval Putra Megatrading Tbk at Enseval Office, Jakarta, to be distributed throughout Indonesia.
  • Growth Improvement in Sales

    Saturday, April 4, 2020
    Growth Improvement in Sales

    Jakarta, April 03, 2020 – PT Kalbe Farma Tbk and Subsidiaries (“Kalbe” or “the Company”) today announced the audited results of the Company for the year 2019.

  • Enseval Commits in Distribution Services of Health Products During the Covid-19 Pandemic

    Wednesday, April 1, 2020
    Enseval Commits in Distribution Services of Health Products During the Covid-19 Pandemic

    Jakarta, April 1 2020 - PT Kalbe Farma Tbk (Kalbe) through one of its subsidiary, PT Enseval Putera Megatrading Tbk (Enseval) is committed to continuing to provide pharmaceutical and health product distribution services to customers to ensure the availability of quality health products in public. In the social distancing situation during the handling of the Covid-19 pandemic, Enseval provides digital health distribution services through the EMOS and MOSHEALTH platforms. Both of these digital platforms are aimed at pharmacies, drug stores or other outlets that must continue to serve the public with their health product needs. 

  • Kalbe Signs a Memorandum of Agreement with the National Disaster Management Agency (BNPB)

    Wednesday, March 25, 2020
    Kalbe Signs a Memorandum of Agreement with the National Disaster Management Agency (BNPB)

    Jakarta, 25 March 2020, PT Kalbe Farma Tbk (Kalbe) today signed a memorandum of understanding with the National Disaster Management Agency (BNPB) in support of the efforts made by BNPB in tackling the spread of the Covid-19 virus. The Memorandum of Agreement is signed directly by Lt. Gen. of the Indonesian Military. Doni Monardo. Chairman of the Task Force for Mitigation Acceleration of Covid-19; while Kalbe is represented by Ongkie Tedjasurja, Director of PT Kalbe Farma TBK., at the BNPB headquarters, Jakarta.

RSS
12345Last